Beta Bionics BBNX 深 沪
已收盘 10-16 16:00:00 美东时间
16.35
-0.960
-5.55%
华盛通- 最 高17.53
- 今 开17.42
- 成交量 66.08万股
- 最 低 16.32
- 昨 收 17.31
- 总市值 7.36亿
- 52周最高 32.71
- 市盈率 静 --
- 换手率 1.47%
- 52周最低 8.80
- 委 比 57.46%
- 总股本 4498.97万
- 历史最高 32.71
- 量 比 0.72
- 振 幅 6.99%
- 历史最低 8.80
- 每 手 1
- 风险率 6.59%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Beta Bionics收跌5.55%，成交额1104.01万美元
10月20-22日上海黄浦江畔，2026可持续全球领导者大会再度来袭。诺奖、图灵奖得主现场讲述科技未来与趋势，更有“解救”焦虑、内卷时代的网红教授——麦克法兰与...
今天 05:51
美股大行评级 | 潜在涨幅386.16%！摩根士丹利维持TeraWulf"超配"评级，上调目标价至65美元
今日重点评级关注：摩根士丹利：维持TeraWulf"超配"评级，目标价从62.5美元升至65美元；摩根士丹利：维持Hut 8"超配"评级，目标价从273美元升至275美元
10-13 12:30
Jefferies Initiates Coverage On Beta Bionics with Buy Rating, Announces Price Target of $30
Jefferies analyst Michael Toomey initiates coverage on Beta Bionics (NASDAQ:BBNX) with a Buy rating and announces Price Target of $30.
10-12 20:05
估值跌至十年低点！巴克莱首次覆盖26家美股医疗科技股，首选史赛克(SYK.US)等
巴克莱分析师Christopher Pasquale周二首次覆盖26家美股医疗科技公司，并将史赛克(SYK.US)和雅培(ABT.US)列入大盘医疗科技股推荐名...
10-08 13:58
美股大行评级 | Meta获4家机构齐升目标价，最高看至995美元！麦当劳遭6家机构下调，最低看至260美元
今日重点评级关注：Canaccord Genuity：维持Aurora Innovation"买入"评级，目标价从15美元升至17美元；摩根大通：维持皇家加勒比邮轮"超配"评级，目标价从345美元升至394美元
09-25 15:55
美股大行评级 | 汽车地带绩后遭10家机构降目标价！最低看至3000美元；美光、微软、Meta齐获看多
今日重点评级关注：Leerink Partners：维持塞德斯医疗"跑赢大市"评级，目标价从70美元升至88美元；HC Wainwright & Co.：维持TriSalus Life Sciences"买入"评级，目标价从11美元升至12美元
09-24 16:10
Wells Fargo Initiates Coverage On Beta Bionics with Overweight Rating, Announces Price Target of $28
Wells Fargo analyst Larry Biegelsen initiates coverage on Beta Bionics (NASDAQ:BBNX) with a Overweight rating and announces Price Target of $28.
09-23 23:30
Beta Bionics Announces Agreement Integrate the iLet® Bionic Pancreas and mint™ with Senseonics’ Eversense® 365
Beta Bionics announced a partnership with Senseonics to integrate the iLet Bionic Pancreas and mint AID systems with Senseonics’ Eversense 365 CGM system. The integrated system is expected to launch in Q4 2026, offering users the most CGM manufacturer options for AID systems. The collaboration aims to expand reach and maximize choice for people with diabetes, combining advanced adaptive AID technology with long-term glucose sensing.
09-22 11:30
美股牛股 | LITE升近10%，Credo升逾7%，Ciena上调长期增长目标提振光通信板块；CIFR升逾10%，AI数据中心转型预期升温；FTAI升近8%
LITE升近10%，Credo升逾7%，Ciena上调长期增长目标提振光通信板块；CIFR升逾10%，AI数据中心转型预期升温；FTAI升近8%，宣布5亿美元股份回购计划>>
09-17 18:46
LuxExperience, Alvotech, Twist Bioscience And Other Big Stocks Moving Higher On Wednesday
U.S. stocks were mixed, with the Nasdaq Composite gaining around 150 points on Wednesday. Shares of LuxExperience BV-ADR (NYSE:LUXE) rose sharply after the company reported fourth-quarter results. LuxExperience reported quarterly losses of 21 cents per share which missed the analyst consensus estima...
09-16 21:57
